rs104894226
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs104894226
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Thymic tumors: relevant molecular data in the clinic.
|
20859122 |
2010 |
rs104894226
|
|
|
0.710 |
GeneticVariation |
BEFREE |
One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation.
|
19861435 |
2009 |
rs1057519704
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
"When a thymic carcinoma ""becomes"" a GIST."
|
23375402 |
2013 |
rs1057519701
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs1057519704
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs1057519711
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs121913513
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs121913517
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs1057519701
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Large-scale analysis of KIT aberrations in Chinese patients with melanoma.
|
21325067 |
2011 |
rs1057519704
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.
|
21969494 |
2011 |
rs1131692239
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.
|
20970876 |
2011 |
rs121913517
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.
|
20736294 |
2010 |
rs1057519711
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma.
|
19461405 |
2009 |
rs121913685
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
|
19861435 |
2009 |
rs121913513
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
|
18448188 |
2008 |
rs1057519711
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.
|
17699867 |
2007 |
rs121913513
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
|
17372901 |
2007 |
rs121913685
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
|
17372901 |
2007 |
rs121913685
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation.
|
15930355 |
2005 |
rs121913685
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.
|
15201427 |
2004 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.
|
12960119 |
2003 |
rs121913517
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.
|
12960119 |
2003 |
rs113488022
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Activating kinase alterations discovered in BRAF V600E-wildtype Langerhans (LCH) and non-Langerhans cell histiocytoses (non-LCH) result in constitutive activation of the mitogen-activated protein kinase and/or phosphoinositide 3-kinases-Akt murine thymoma pathways.
|
27101528 |
2016 |